Possibilities for Gilead Sciences in Q2 2018 Earnings Release
Gilead Sciences (GILD) is expected to report its second-quarter earnings on July 25. Analysts expect Gilead Sciences’ revenues to decline 27.18%, from $7.14 billion in Q2 2017 to $5.2 billion in Q2 2018. In Q2 2017, its revenues shrunk 8.17%.